Dallas XEOMIN® $9.50 Per Unit PLUS $50 Gift Card
Dallas Xeomin Wrinkle Treatment For Forehead, Eyes, Chin and Neck
Dallas Xeomin Hyperhidrosis Treatment
Now you can purchase an entire years Xeomin wrinkle reduction treatments and Xeomin hyperhidrosis treatments in Dallas and Southlake at $8/unit
XEOMIN® (incobotulinumtoxinA) is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.
Another very important consideration to treating aging skin below the dermis is the treatment of wrinkles due to contraction of underlying muscles of expression; such as frown lines, forehead lines, corw’s feet.
Neuromodulators like Xeomin, Botox and Dysport are an excellent option to relax the expressive muscles to reduce dynamic wrinkles like frown lines, laugh lines, crow’s feet, forehead wrinkles, smoker’s lines, and other wrinkles caused by your expression or muscle movement. It is important to know that the neuromodulators work on the muscles of expression and not on the skin and are best to start before you actually develop a deep wrinkle in the skin itself; think of neuromodulators, Botox, Xeomin and Dysport, as more of a “preventive” rather than “corrective” treatment.
The trick is to relax the expressive muscles just enough to release the skin wrinkles without “frozen” expression or “pointy eyebrows”.
In the hands of an experienced physician, Botox, Xeomin and Dysport can also be used for more advanced cosmetic skin treatments such as:
- Botox and Xeomin for jaw reduction or facial softening
- Botox and Xeomin for chin wrinkles
- Botox and Xeomin for platysmal folds or neck wrinkles
- Botox and Xeomin for non-surgical “eyebrow lift”
Dr. Malik has been treating patients in Southlake and Dallas using advanced injection techniques for jaw reduction, chin wrinkles and neck wrinkles with great results.
Call 888-210-9693 for your Botox / Xeomin treatment in Dallas and Southlake for dynamic lines or jaw reduction.